I see the potential thats why im still here,but thats all it is so far potential
He's been banging on for years
AVITA BEGINS TRADING UNDER AVH
26 June 2008: Avita Medical Limited (formerly named Clinical Cell Culture Ltd) today begun trading
on the ASX under its new code AVH.
On Tuesday the company completed a 10 for 1 share consolidation. Avita Medical now has
93,476,181 shares on issue.
The company is also pleased to release an Investor Update (attached) for shareholders. Avita
Medical Managing Director Bill Dolphin said the merged company was making
significant progress and expected to announce a number of key developments in coming
weeks.
“As a merged entity we have hit the ground running, particularly in Australia where our respiratory
products are gaining significant sales traction,” said Dr Dolphin. ----------------------------------
TRUTH OR ABSOLUTE LIES
“We have established a number of key milestones for the coming few months and look forward to
updating shareholders on our progress in due course,” he said.
Hit the "gound running" and weve been crawling ever since.
- Forums
- ASX - By Stock
- AVH
- this is rubbish
this is rubbish, page-3
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.82 |
Change
0.140(3.80%) |
Mkt cap ! $266.9M |
Open | High | Low | Value | Volume |
$3.83 | $3.87 | $3.77 | $1.433M | 374.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | $3.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.86 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | 3.820 |
2 | 860 | 3.800 |
1 | 4 | 3.780 |
1 | 2000 | 3.770 |
1 | 7963 | 3.760 |
Price($) | Vol. | No. |
---|---|---|
3.860 | 200 | 1 |
3.870 | 9629 | 2 |
3.880 | 17056 | 3 |
3.890 | 6504 | 2 |
3.900 | 8380 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online